Monday, January 06, 2020 11:30:25 PM
Imagin has scheduled a conference call for Tuesday, January 7,
2020, at 5:00 p.m. ET during which the results will be discussed.
Live Call: 844-602-0380 (Canada and the United States)
862-298-0970 (International)
Replay: 877-481-4010 (Canada and the United States)
Replay ID: 57013
The call will also be broadcast live and archived on the Company's website at
www.imaginmedical.com under "Events & Presentations."
It will be interesting to hear CEO Jim Hutchins' ideas about why IMEXF has experienced such a significant spike in buyer interest since the beginning of 2020. Tune in.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM